Rebranding – in it for the long haul
October 16, 2003Medical Communications branding, life cycle
In February, the Government announced plans for a new Hib (Haemophilus influenzae type b) vaccine booster, but with the MMR …
Managing alliances for performance
October 16, 2003Research and Development alliance
These days no pharmaceutical company would be caught admitting that they did not have an alliance strategy. After all, the …
Communications before launch
October 16, 2003Medical Communications communications, pre-launch
Producing and launching a profitable drug is no easy task and requires cohesive planning throughout all stages of the product's …
From lab to limousine
October 16, 2003Research and Development biotech, start-up
Attend any networking conference bringing together fledgling biotechnology companies and investors, whether financial or industry, and you will repeatedly hear …
Power to the patient
October 16, 2003Medical Communications consumers assocation, patient information
Patient information is a growing issue. Publicity around issues such as the variation in treatment across the country – so-called …
Emotional relationships: marriage vs. holiday romances
October 15, 2003Research and Development CRO, contract research, contract research organisation
If you were to ask leading CRO executives they would tell you that blue chip pharma companies outsource their critical …
We’re letting you go
October 15, 2003Business Services recruitment, redundancy
When we were at school, we were misled into a fools' paradise, which told us that if we were good …
The Stone Age salesforce
October 15, 2003Sales and Marketing sales force
Here are a few thoughts on why your sales and marketing team will only respond so far to the training …
Technology in clinical trials
October 15, 2003Research and Development clincial testing, technology
The major drive for the pharma industry is the pressure to reduce drug development times and costs. Although paper-based processes …
Waiting for the upturn
October 15, 2003Research and Development drug development, pipelines
Estimates vary considerably, but many analysts put the current cost of bringing a drug to market at around $800 million, …
Project management – you get what you pay for
October 15, 2003Research and Development project management
Pharma projects have project managers. Technology projects have project managers. But there is a world of difference between them. That …
DTC: the new philosopher’s stone?
October 15, 2003Medical Communications EU, advertising, direct to consumer, dtc
Strategic communications planning
October 15, 2003Medical Communications communications, planning, strategic, targeting
Once your product has hit the market, can strategic communications still play a part? It can if you combine it …
Unoriginal sin
October 14, 2003Medical Communications advertising, creativity
'OK, so its been done before a couple of times. But badly.' It is the meeting from hell. You may …
The management of schizophrenia
October 14, 2003Sales and Marketing NICE, clinical guidelines, healthcare, schizophrenia
The publication of NICE's clinical guidelines on the management of schizophrenia in December marks a significant milestone – the first …
Out with the field force
October 14, 2003Sales and Marketing CRM, customer relationship management
It was with great delight that I accepted the Pharmafocus offer to spend a day on the road with Senior …
Sales technology – inside out, or outside in?
October 14, 2003Sales and Marketing CRM, SFA, customer relationship managmeent, salesforce automation
What does that mean? Well, think about it: CRM systems, which are meant to give the business, and in particular, …
The PM Society Advertising Awards 2002
October 14, 2003Medical Communications advertising, awards, pm society
This year the PM Society added a new category, Best Abbreviated Advert, to better reflect the breadth of advertising formats, …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
